Collateral effects of the SARS-CoV-2 pandemic on oncologic surgery in Bavaria

Abstract Background The ongoing SARS-COV-2 pandemic has severe implications for people and healthcare systems everywhere. In Germany, worry about the consequences of the pandemic led to the deferral of non-emergency surgeries. Tumor surgery accounts for a large volume in the field of visceral surger...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Thomas Dienemann, Frank Brennfleck, Alexander Dejaco, Robert Grützmann, Johannes Binder, Christian Krautz, Christian Stöß, Carsten Jäger, Helmut Friess, Hans Jürgen Schlitt, Stefan M. Brunner
Formato:	article
Lenguaje:	EN
Publicado:	BMC 2021
Materias:	SARS-CoV-2 COVID-19 Oncologic surgery Oncology Patient care Surgery RD1-811
Acceso en línea:	https://doaj.org/article/fe26cdba2cd54415be35e9870b8bc2f7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:fe26cdba2cd54415be35e9870b8bc2f7
record_format	dspace
spelling	oai:doaj.org-article:fe26cdba2cd54415be35e9870b8bc2f72021-12-05T12:06:29ZCollateral effects of the SARS-CoV-2 pandemic on oncologic surgery in Bavaria10.1186/s12893-021-01404-y1471-2482https://doaj.org/article/fe26cdba2cd54415be35e9870b8bc2f72021-12-01T00:00:00Zhttps://doi.org/10.1186/s12893-021-01404-yhttps://doaj.org/toc/1471-2482Abstract Background The ongoing SARS-COV-2 pandemic has severe implications for people and healthcare systems everywhere. In Germany, worry about the consequences of the pandemic led to the deferral of non-emergency surgeries. Tumor surgery accounts for a large volume in the field of visceral surgery and cannot be considered purely elective. It is not known how the SARS-COV-2 pandemic has changed the surgical volume in tumor patients. Methods Retrospective analysis of the amount of oncological surgeries in three academic visceral surgery departments in Bavaria, Germany, in 2020. Procedures were split into subgroups: Upper Gastrointestinal (Upper GI), Colorectal, Hepato-Pancreato-Biliary (HPB), Peritoneal and Endocrine. Procedures in 2020 were compared to a reference period from January 1st, 2017 to December 31st 2019. Surgical volume was graphically merged with SARS-COV-2 incidence and the number of occupied ICU beds. Results Surgical volume decreased by 7.6% from an average of 924 oncologic surgeries from 2017 to 2019 to 854 in 2020. The decline was temporally associated with the incidence of infections and ICU capacity. Surgical volume did not uniformly increase to pre-pandemic levels in the months following the first pandemic wave with lower SARS-COV-2 incidence and varied according to local incidence levels. The decline was most pronounced in colorectal surgery where procedures declined on average by 26% following the beginning of the pandemic situation. Conclusion The comparison with pre-pandemic years showed a decline in oncologic surgeries in 2020, which could have an impact on lost life years in non-COVID-19 patients. This decline was very different in subgroups which could not be solely explained by the pandemic.Thomas DienemannFrank BrennfleckAlexander DejacoRobert GrützmannJohannes BinderChristian KrautzChristian StößCarsten JägerHelmut FriessHans Jürgen SchlittStefan M. BrunnerBMCarticleSARS-CoV-2COVID-19Oncologic surgeryOncologyPatient careSurgeryRD1-811ENBMC Surgery, Vol 21, Iss 1, Pp 1-8 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	SARS-CoV-2 COVID-19 Oncologic surgery Oncology Patient care Surgery RD1-811
spellingShingle	SARS-CoV-2 COVID-19 Oncologic surgery Oncology Patient care Surgery RD1-811 Thomas Dienemann Frank Brennfleck Alexander Dejaco Robert Grützmann Johannes Binder Christian Krautz Christian Stöß Carsten Jäger Helmut Friess Hans Jürgen Schlitt Stefan M. Brunner Collateral effects of the SARS-CoV-2 pandemic on oncologic surgery in Bavaria
description	Abstract Background The ongoing SARS-COV-2 pandemic has severe implications for people and healthcare systems everywhere. In Germany, worry about the consequences of the pandemic led to the deferral of non-emergency surgeries. Tumor surgery accounts for a large volume in the field of visceral surgery and cannot be considered purely elective. It is not known how the SARS-COV-2 pandemic has changed the surgical volume in tumor patients. Methods Retrospective analysis of the amount of oncological surgeries in three academic visceral surgery departments in Bavaria, Germany, in 2020. Procedures were split into subgroups: Upper Gastrointestinal (Upper GI), Colorectal, Hepato-Pancreato-Biliary (HPB), Peritoneal and Endocrine. Procedures in 2020 were compared to a reference period from January 1st, 2017 to December 31st 2019. Surgical volume was graphically merged with SARS-COV-2 incidence and the number of occupied ICU beds. Results Surgical volume decreased by 7.6% from an average of 924 oncologic surgeries from 2017 to 2019 to 854 in 2020. The decline was temporally associated with the incidence of infections and ICU capacity. Surgical volume did not uniformly increase to pre-pandemic levels in the months following the first pandemic wave with lower SARS-COV-2 incidence and varied according to local incidence levels. The decline was most pronounced in colorectal surgery where procedures declined on average by 26% following the beginning of the pandemic situation. Conclusion The comparison with pre-pandemic years showed a decline in oncologic surgeries in 2020, which could have an impact on lost life years in non-COVID-19 patients. This decline was very different in subgroups which could not be solely explained by the pandemic.
format	article
author	Thomas Dienemann Frank Brennfleck Alexander Dejaco Robert Grützmann Johannes Binder Christian Krautz Christian Stöß Carsten Jäger Helmut Friess Hans Jürgen Schlitt Stefan M. Brunner
author_facet	Thomas Dienemann Frank Brennfleck Alexander Dejaco Robert Grützmann Johannes Binder Christian Krautz Christian Stöß Carsten Jäger Helmut Friess Hans Jürgen Schlitt Stefan M. Brunner
author_sort	Thomas Dienemann
title	Collateral effects of the SARS-CoV-2 pandemic on oncologic surgery in Bavaria
title_short	Collateral effects of the SARS-CoV-2 pandemic on oncologic surgery in Bavaria
title_full	Collateral effects of the SARS-CoV-2 pandemic on oncologic surgery in Bavaria
title_fullStr	Collateral effects of the SARS-CoV-2 pandemic on oncologic surgery in Bavaria
title_full_unstemmed	Collateral effects of the SARS-CoV-2 pandemic on oncologic surgery in Bavaria
title_sort	collateral effects of the sars-cov-2 pandemic on oncologic surgery in bavaria
publisher	BMC
publishDate	2021
url	https://doaj.org/article/fe26cdba2cd54415be35e9870b8bc2f7
work_keys_str_mv	AT thomasdienemann collateraleffectsofthesarscov2pandemicononcologicsurgeryinbavaria AT frankbrennfleck collateraleffectsofthesarscov2pandemicononcologicsurgeryinbavaria AT alexanderdejaco collateraleffectsofthesarscov2pandemicononcologicsurgeryinbavaria AT robertgrutzmann collateraleffectsofthesarscov2pandemicononcologicsurgeryinbavaria AT johannesbinder collateraleffectsofthesarscov2pandemicononcologicsurgeryinbavaria AT christiankrautz collateraleffectsofthesarscov2pandemicononcologicsurgeryinbavaria AT christianstoß collateraleffectsofthesarscov2pandemicononcologicsurgeryinbavaria AT carstenjager collateraleffectsofthesarscov2pandemicononcologicsurgeryinbavaria AT helmutfriess collateraleffectsofthesarscov2pandemicononcologicsurgeryinbavaria AT hansjurgenschlitt collateraleffectsofthesarscov2pandemicononcologicsurgeryinbavaria AT stefanmbrunner collateraleffectsofthesarscov2pandemicononcologicsurgeryinbavaria
_version_	1718372294398574592

Collateral effects of the SARS-CoV-2 pandemic on oncologic surgery in Bavaria

Ejemplares similares